SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form C/A - Offering Statement: [Amend]
SEC Accession No. 0001104659-20-113491
Filing Date
2020-10-08
Accepted
2020-10-08 17:30:09
Documents
6

Document Format Files

Seq Description Document Type Size
1 primary_doc.html C/A  
1 primary_doc.xml C/A 10252
2 SUPPLEMENT TO THE OFFERING MEMORANDUM tm2032804d1_ex99.pdf EX-99 621214
3 OFFERING MEMORANDUM tm2032804d1_ex99a.pdf EX-99 642229
4 WEFUNDER CAMPAIGN PAGE tm2032804d1_ex99b.pdf EX-99 1209772
5 VIDEO TRANSCRIPTS tm2032804d1_ex99c.pdf EX-99 34117
6 REG CF INVESTOR DECK tm2032804d1_ex99d.pdf EX-99 2198935
  Complete submission text file 0001104659-20-113491.txt   6492755
Mailing Address 505 IRVING AVENUE SUITE 3100 A-B SYRACUSE NY 13210
Business Address 505 IRVING AVENUE SUITE 3100 A-B SYRACUSE NY 13210 607-227-4400
Quadrant Biosciences Inc (Filer) CIK: 0001651239 (see all company filings)

IRS No.: 473417864 | State of Incorp.: DE | Fiscal Year End: 1231
Type: C/A | Act: 33 | File No.: 020-26816 | Film No.: 201231611
SIC: 2834 Pharmaceutical Preparations